1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. Moderna, Inc.
  6. News
  7. Summary
    MRNA   US60770K1079

MODERNA, INC.

(MRNA)
  Report
Delayed Quote. Delayed Nasdaq - 05/25 04:00:00 pm
130.85 USD   -0.92%
05/25SECTOR UPDATE : Health Care Stocks End Near Unchanged
MT
05/25SECTOR UPDATE : Health Care Stocks Falling This Afternoon
MT
05/25SECTOR UPDATE : Health Care
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

UBS Initiates Coverage on Moderna With Neutral Rating, $221 Price Target

01/21/2022 | 12:21pm EDT


© MT Newswires 2022
All news about MODERNA, INC.
05/25SECTOR UPDATE : Health Care Stocks End Near Unchanged
MT
05/25SECTOR UPDATE : Health Care Stocks Falling This Afternoon
MT
05/25SECTOR UPDATE : Health Care
MT
05/25Bioquebec - moderna manufacturing facility opening in montreal
AQ
05/25French health body backs new COVID vaccine booster campaign for this autumn
RE
05/24Moderna's CEO Stephane Bancel to Exercise Shares, Intends to Donate Proceeds to Charity
MT
05/24GLOBAL MARKETS LIVE : Broadcom, Airbnb, Roche, Toyota, Uber
05/24WALL STREET STOCK EXCHANGE : Snap cut the rally short
05/24Rubius Therapeutics Names Noubar Afeyan Chairman; Shares Rise Pre-Bell
MT
05/24TRANSCRIPT : Moderna, Inc. Presents at UBS Global Healthcare Conference, May-24-2022 09:15..
CI
More news
Analyst Recommendations on MODERNA, INC.
More recommendations
Financials (USD)
Sales 2022 22 069 M - -
Net income 2022 11 501 M - -
Net cash 2022 18 081 M - -
P/E ratio 2022 4,81x
Yield 2022 -
Capitalization 52 047 M 52 047 M -
EV / Sales 2022 1,54x
EV / Sales 2023 3,11x
Nbr of Employees 2 700
Free-Float 90,6%
Chart MODERNA, INC.
Duration : Period :
Moderna, Inc. Technical Analysis Chart | MRNA | US60770K1079 | MarketScreener
Technical analysis trends MODERNA, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Last Close Price 130,85 $
Average target price 212,69 $
Spread / Average Target 62,5%
EPS Revisions
Managers and Directors
Stéphane Bancel Chief Executive Officer & Director
Stephen Hoge President
David W. Meline Chief Financial Officer
Noubar B. Afeyan Chairman
Juan Andres Chief Technical Operations & Quality Officer
Sector and Competitors
1st jan.Capi. (M$)
MODERNA, INC.-48.48%52 047
LONZA GROUP AG-27.13%42 896
IQVIA HOLDINGS INC.-27.93%38 232
SEAGEN INC.-11.73%24 569
ICON PUBLIC LIMITED COMPANY-31.56%17 581
CELLTRION, INC.-22.73%15 861